Financial Performance - For the three months ended March 31, 2021, the group achieved a consolidated revenue of RMB 124,407,625, representing an increase of 81.55% compared to RMB 68,523,880 for the same period last year[6] - The consolidated gross profit for the same period was RMB 13,722,640, reflecting a significant increase of 253.42% from RMB 3,882,817 in the previous year[6] - The loss attributable to equity holders of the company was RMB 165,625, a decrease of 97.04% compared to a loss of RMB 5,591,384 in the same period last year[6] - The basic loss per share for the period was RMB 0.009, compared to RMB 0.295 for the same period last year[6] - The group reported a pre-tax loss of RMB 1,493,248, significantly improved from a loss of RMB 5,945,839 in the previous year[7] - The total sales cost for the period was RMB 110,684,985, compared to RMB 64,641,063 in the previous year[7] - The research and development and administrative expenses amounted to RMB 7,455,064, compared to RMB 5,568,630 in the previous year[7] - The comprehensive gross profit for the same period was RMB 13,722,640, which is a 253.42% increase from RMB 3,882,817 year-on-year, resulting in a gross margin of 11.03%, up by 5.36% from 5.67%[18] Revenue Sources - The revenue from fertilizer products was RMB 124,379,590, up from RMB 68,473,752 in the previous year, while revenue from elderly care and health services was RMB 28,035, down from RMB 50,128[9] Dividends and Shareholder Returns - The group did not recommend the payment of any dividend for the three months ended March 31, 2021[6] - The company does not recommend the payment of an interim dividend for the three months ended March 31, 2021, consistent with no dividend declared in the same period last year[15] Business Strategy and Development - The company is actively expanding its biocomposite fertilizer business and elderly care services, focusing on the integration of medical and elderly care services[17] - The company plans to adopt new marketing strategies to promote its new series of fertilizers, aiming for sustainable development in the biocomposite fertilizer sector[22] - The company is experiencing slow development in its EEG detection business but is actively seeking new partnerships to enhance growth in this area[23] - The company is committed to improving its elderly care services by developing or investing in high-end elderly care institutions and enhancing its professional capabilities in elderly care[23] - The company is focused on biomedical engineering and aims to enhance its market presence[38] - The company plans to continue its research and development efforts in new products and technologies[38] - The company is exploring potential market expansions to increase its competitive edge[38] - The company emphasizes the importance of strategic partnerships and collaborations in its growth strategy[38] - The company aims to improve operational efficiency through innovative practices[38] - The company is dedicated to maintaining high standards of corporate governance[38] - The company is focused on enhancing shareholder value through sustainable growth initiatives[38] Financial Liabilities and Governance - The company faces a contingent liability of RMB 3,000,000 related to bank loans secured by its subsidiaries as of March 31, 2021, compared to zero as of December 31, 2020[19] - The company’s treasury policy involves bank borrowings settled in RMB, with cash balances deposited in licensed banks in China[21] - The company has committed to adhering to the corporate governance principles outlined in the GEM Listing Rules[37] - The company did not establish any arrangements allowing directors or supervisors to profit from purchasing company shares during the review period[26] - The company has not approved any new share option plans during the period ending March 31, 2021[34] - There were no management contracts signed for overall business or any major business during the period ending March 31, 2021[35] - The company has not disclosed any competitive interests or conflicts of interest involving its directors or management during the review period[32] Shareholder Information - As of March 31, 2021, major shareholders include Tianjin TEDA International Entrepreneurship Center with 182,500,000 shares (9.63%), Shenzhen Xiangyong Investment Co., Ltd. with 180,000,000 shares (9.50%), and Shandong Zhinong Fertilizer Co., Ltd. with 180,000,000 shares (9.50%)[27] Audit and Reporting - The company’s audit committee, consisting of three independent non-executive directors, reviewed the financial results for the first quarter ending March 31, 2021[33] - The report will be available for at least seven days on the GEM website and the company's website[38] - The company is committed to transparency and will publish its announcements on its official platforms[38]
泰达生物(08189) - 2021 Q1 - 季度财报